Collaborative and Seamless Care in Oncology : a Study in Primary Care to Measure and Reinforce Safety and Adherence to Oral Cancer Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 43
- 试验地点
- 2
- 主要终点
- Change in Medication adherence
研究概览
简要总结
The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.
详细描述
80 patients will be included in swiss-romande hospitals and private oncologists and followed by thirty study pharmacies. Each refusal and drop-out will be documented. Follow-up duration is 48 weeks, with a motivational interviewing at least every three months. Patient adherence will be assessed electronically by MEMS (Medication Event Monitoring System).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years and older
- •Treated for a cancer with oral medication (letrozol, exemestan,imatinib, sunitinib, nilotinib, everolimus, deferasirox)
- •French speaking
排除标准
- 未提供
结局指标
主要结局
Change in Medication adherence
时间窗: 3 months, 6 months, 9 months, 12 months
MEMS data, completed by informations given in motivational interviewing
次要结局
- Program implementation(1 year)
- Effect of Adverse Drug Reaction (ADR) on medication adherence(1 year)
- Oncologists, nurses, pharmacists and patients satisfaction(1 year)
- Change in Adverse Drug Reaction (ADR)(3 months, 6 months, 9 months, 12 months)
研究者
Marie Schneider
Dr
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland